HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Daniel E Singer Selected Research

Warfarin (Coumadin)

7/2013End of study transition from study drug to open-label vitamin K antagonist therapy: the ROCKET AF experience.
7/2013Efficacy and safety of rivaroxaban in patients with heart failure and nonvalvular atrial fibrillation: insights from ROCKET AF.
6/2013Clinical outcomes with rivaroxaban in patients transitioned from vitamin K antagonist therapy: a subgroup analysis of a randomized trial.
5/2013Outcomes after cardioversion and atrial fibrillation ablation in patients treated with rivaroxaban and warfarin in the ROCKET AF trial.
2/2013Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation).
1/2013Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts.
10/2012Anticoagulation therapy for patients with non-valvular atrial fibrillation: comparison of decision analytic model recommendations and real-world warfarin prescription use.
7/2012Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.
4/2012A new era in stroke prevention for atrial fibrillation: comment on "current trial-associated outcomes with warfarin in prevention of stroke in patients with nonvalvular atrial fibrillation.
4/2012Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $490.00 USD

Daniel E Singer Research Topics

Disease

35Stroke (Strokes)
09/2013 - 11/2002
30Atrial Fibrillation
09/2013 - 11/2002
17Hemorrhage
07/2013 - 11/2002
13Embolism (Embolus)
09/2013 - 11/2003
8Intracranial Hemorrhages (Intracranial Hemorrhage)
07/2012 - 11/2003
8Thromboembolism
11/2010 - 11/2003
7Hypertension (High Blood Pressure)
02/2012 - 06/2002
6Heart Failure
07/2013 - 09/2004
5Diabetes Mellitus
02/2012 - 08/2002
4Transient Ischemic Attack
01/2013 - 09/2004
4Pneumonia (Pneumonitis)
09/2002 - 02/2002
3Thrombosis (Thrombus)
06/2008 - 03/2003
2Cardiovascular Diseases (Cardiovascular Disease)
12/2006 - 06/2002
2Cerebral Hemorrhage
04/2004 - 07/2003
1Tachycardia (Tachyarrhythmias)
10/2009
1Unstable Angina
12/2006
1Myocardial Infarction
12/2006
1Respiratory Tract Infections (Respiratory Tract Infection)
10/2003
1Sinusitis
05/2003
1Diabetes Complications
08/2002
1Hypercholesterolemia
06/2002
1Liver Diseases (Liver Disease)
05/2002
1Leukopenia
05/2002
1Anoxia (Hypoxia)
05/2002
1Hypothermia
05/2002
1Neoplasms (Cancer)
02/2002
1Dementia (Dementias)
02/2002
1Intravenous Substance Abuse
02/2002

Drug/Important Bio-Agent (IBA)

33Warfarin (Coumadin)FDA LinkGeneric
07/2013 - 03/2003
13Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
08/2013 - 11/2002
10rivaroxabanIBA
09/2013 - 09/2011
9Vitamin KFDA Link
09/2013 - 11/2002
7Factor Xa (Coagulation Factor Xa)IBA
09/2013 - 09/2005
6AnticoagulantsIBA
07/2012 - 11/2002
2clopidogrel (Plavix)FDA Link
02/2012 - 09/2005
2Fibrinolytic Agents (Antithrombotic Agents)IBA
09/2005 - 02/2004
2Anti-Bacterial Agents (Antibiotics)IBA
10/2003 - 05/2003
2Urea (Carbamide)FDA LinkGeneric
05/2002 - 02/2002
2NitrogenIBA
05/2002 - 02/2002
1EOSIBA
07/2013
1CreatinineIBA
01/2013
1triflusalIBA
04/2009
1Bupropion (Wellbutrin)FDA LinkGeneric
12/2006
1ThrombinFDA Link
09/2005
1ximelagatran (Exanta)IBA
09/2005
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
09/2005
1CholesterolIBA
05/2004
1Calcium Channels (Calcium Channel)IBA
01/2004
1Digoxin (Digitek)FDA LinkGeneric
01/2004
1Calcium Channel Blockers (Blockers, Calcium Channel)IBA
01/2004
1Heparin (Liquaemin)FDA LinkGeneric
03/2003
1factor V LeidenIBA
02/2003
1Glucose (Dextrose)FDA LinkGeneric
08/2002
1Hemoglobins (Hemoglobin)IBA
08/2002

Therapy/Procedure

3Electric Countershock (Cardioversion)
05/2013 - 09/2004
3Length of Stay
12/2006 - 02/2002
2Defibrillators (Defibrillator)
02/2010 - 10/2009
1Thrombolytic Therapy
09/2004
1Artificial Respiration (Mechanical Ventilation)
09/2002
1Intensive Care (Surgical Intensive Care)
09/2002
1Drug Therapy (Chemotherapy)
06/2002
1Home Nursing (Nursing, Home)
02/2002
1Resuscitation Orders (Do Not Resuscitate Orders)
02/2002